Efficacy and safety evaluation of HSD‐1 inhibitor ABT‐384 in Alzheimer's disease
Year: 2014
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Alzheimer s & Dementia
Authors: Gerard J. Marek, David A. Katz, Andreas Meier, Nicholas Greco, Wuyan Zhang, Wei Liu, Robert A. Lenz
Institutions: AbbVie (United States), Amgen (United States)
Language: English
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2130325529